Treatment outcomes 24 months after initiating short, all-oral bedaquiline-containing or injectable-containing rifampicin-resistant tuberculosis treatment regimens in South Africa: a retrospective cohort study

BACKGROUND: There is a need for short and safe all-oral treatment of rifampicin-resistant tuberculosis. We compared outcomes up to 24 months after treatment initiation for patients with rifampicin-resistant tuberculosis in South Africa treated with a short, all-oral bedaquiline-containing regimen (b...

Descripción completa

Detalles Bibliográficos
Autores principales: Ndjeka, Norbert, Campbell, Jonathon R, Meintjes, Graeme, Maartens, Gary, Schaaf, H Simon, Hughes, Jennifer, Padanilam, Xavier, Reuter, Anja, Romero, Rodolfo, Ismail, Farzana, Enwerem, Martin, Ferreira, Hannetjie, Conradie, Francesca, Naidoo, Kogieleum, Menzies, Dick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science ;, The Lancet Pub. Group 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9217754/
https://www.ncbi.nlm.nih.gov/pubmed/35512718
http://dx.doi.org/10.1016/S1473-3099(21)00811-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9217754/
https://www.ncbi.nlm.nih.gov/pubmed/35512718
http://dx.doi.org/10.1016/S1473-3099(21)00811-2

Ejemplares similares